Resources
Filter by Topic
- Blogs
by Meg Richards, PhD, MPH Executive Director of Solutions, Panalgo
- Case Study
A real world case study
- White Paper
A White Paper by Meg Richards, PhD, MPH
- Blogs
by Mike Munsell, PhD Director of Research, Panalgo
- Blogs
DIA 2023 was in Panalgo’s hometown of Boston last week and as usual, it did not disappoint. This year’s theme was ‘Illuminate’ – shining a...
What’s next for the life sciences industry? Four trends to watch in 2024
2023 was an eventful year for the life sciences industry, with the Inflation Reduction Act (IRA) and game-changing technology like ChatGPT dominating the headlines. Will
Worries and Hopes for Healthcare Delivery in 2024
Industry experts from Norstella – a family of brands that includes, Citeline, the Dedham Group, Evaluate, MMIT, and Panalgo, and whose data and technologies support
Building Effective Real World Evidence Studies to Support New Indications for Established Products
In this article from PharmExec.com, Panalgo’s Executive Director of Solutions Meg Richards, and Dr. Samy Suissa, Founder of the Canadian Network for Observational Drug Effect
Leaning Into RWE: The IRA is Here, So Now’s the Time
Manufacturers are continuing to wrestle with the effects of the Inflation Reduction Act (IRA) on their business plans and revenue streams. Although some of the
Conclusions from Copenhagen: Highlights of ISPOR EU 2023
ISPOR Europe 2023, with the largest number of delegates on record (5,600) was held in wonderful, wonderful Copenhagen (cue the Danny Kaye waltz) last week.
How RWE Improves Evidence Generation Across the Product Life Cycle
Real-world evidence (RWE) is crucial for biopharmaceutical companies and other life sciences organizations to develop the right products for the marketplace. RWE is a powerful
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization